(redirected from pancreatic cancer)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to pancreatic cancer: pancreatitis, pancreas


Fifth letter of a Nasdaq stock symbol specifying that it is the third preferred bond of the company.


1. On a stock transaction table, a symbol indicating that a dividend was paid after a stock split.

2. A symbol appearing next to a bond listed on NASDAQ indicating that the bond is a company's third preferred bond. All NASDAQ listings use a four-letter abbreviation; if the letter "I" follows the abbreviation, this indicates that the security being traded is a third preferred bond.


Used in the dividend column of stock transaction tables to indicate that the dividend was paid after a stock dividend or split: Lehigh s.20i.
Mentioned in ?
References in periodicals archive ?
Death rates for pancreatic cancer are increasing while the death rates for other cancers are declining.
It estimates that survival rates for patients diagnosed with pancreatic cancer via an emergency route are very low with one-year survival at only 9% compared to 26% for those diagnosed as a result of a GP referral.
In contrast, individuals with just a single relative with pancreatic cancer were at twice the risk of pancreatic cancer whether or not the relative with pancreatic cancer was diagnosed before or after the age of 50.
Abdominal pain: Pain can occur when the cancer presses against nerves in the abdominal area but only about half of all pancreatic cancer patients have any pain at the time of diagnosis.
The Pancreatic Cancer Action Network is asking supporters to participate in six activities to increase awareness this November:
The Pancreatic Cancer Pipeline Review, H1 2014 report provides an overview of the Pancreatic Cancer's therapeutic pipeline.
A recent report by Pancreatic Cancer UK called for greater funding after highlighting an urgent need to redress a "historical legacy of neglect" surrounding investment into pancreatic cancer research in the UK.
The animals offer a "very faithful model of pancreatic cancer," says David Tuveson of the University of Pennsylvania in Philadelphia, who led the new work.
Fore Pharma's latest report 'Global Pancreatic Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Pancreatic Cancer market.
26, 2015 /PRNewswire-USNewswire/ -- The Pancreatic Cancer Action Network is leading the way to change the course of history for pancreatic cancer with a new goal to raise $200 million by 2020.
Pancreatic cancer is the fourth most common cause of cancer death in the EU and kills 95% of people affected

Full browser ?